Blog
RSS FeedPosted by Michael Wonder on 04 Jan 2017
Drop in FDA approvals (and new administration) rekindles fears for the future of pharma
3 December 2016 - 2016 was a bummer! After years of rising FDA approvals that swelled to an all-time high of ...
Posted by Michael Wonder on 15 Dec 2016
A new type of molecular medicine may be needed to halt cancers
16 December 2016 - Doctors must look to proteins rather than genes to tackle tumours. ...
Posted by Michael Wonder on 15 Dec 2016
Transforming evidence generation to support health and health care decisions
14 December 2016 - Making better choices about health and health care requires the best possible evidence. Unfortunately, many of the ...
Posted by Michael Wonder on 14 Dec 2016
Obama signs $6.3 billion law for cancer research, drug treatment
14 December 2016 - President Barack Obama has signed into law legislation that makes new investments in cancer research and battling ...
Posted by Michael Wonder on 28 Nov 2016
Republicans reach deal to pass Cures Act by end of year, but Democrats pushing for changes
27 November 2016 - House and Senate leaders announced late Friday night that they had finally hammered out a deal ...
Posted by Michael Wonder on 17 Nov 2016
FDA research to help speed development of Zika virus vaccines and therapeutics
17 November 2016 - Neonatal mouse model provides a new platform for Zika virus research. ...
Posted by Michael Wonder on 16 Nov 2016
Trump should be good medicine for the pharmaceutical industry. Here’s why
15 November 2016 - The holidays came early for the pharmaceutical industry this year. ...
Posted by Michael Wonder on 15 Nov 2016
Trump just dropped a big hint to the pharmaceutical industry
14 November 2016 - A single sentence in President-elect Donald Trump's health-care platform sends a strong hint to the drug ...
Posted by Michael Wonder on 26 Oct 2016
Big pharma is gearing up to defend drug prices
25 October 2016 - The skyrocketing costs of prescription drugs has been noticeably absent from discussion in the presidential debates — ...
Posted by Michael Wonder on 17 Oct 2016
FDA awards 21 grants to stimulate product development for rare diseases
17 October 2016 - The U.S. FDA today announced that it has awarded 21 new clinical trial research grants totaling ...
Posted by Michael Wonder on 12 Oct 2016
Undermining value-based purchasing — lessons from the pharmaceutical industry
12 October 2016 - In 2015, the U.S. Department of Health and Human Services announced a goal of linking at ...
Posted by Michael Wonder on 12 Oct 2016
What experimental drug? Most companies don’t post compassionate use policies
11 October 2016 - As patients clamour for greater access to experimental medicines, a survey released Tuesday finds that ...
Posted by Michael Wonder on 09 Oct 2016
Teva and Celltrion announce exclusive biosimilar commercial partnership
6 October 2016 - Teva Pharmaceutical Industries Ltd and Celltrion Healthcare have announced that the companies have entered into an exclusive ...
Posted by Michael Wonder on 03 Oct 2016
Obama extends controversial program for rare pediatric drugs
30 September 2016 - Despite objections from his own regulators, President Barack Obama signed into law a bill on Friday ...
Posted by Michael Wonder on 29 Sep 2016
FDA eyes new diabetes outcome measures
29 September 2016 - A recent FDA workshop brought new diabetes outcome measures to the table, focusing on patient-oriented outcome measures. ...